The gut microbiota and host health: a new clinical frontier
Кишечная микробиота и здоровье организма-хозяина: новый клинический рубеж
2015-09-02
SCID: 54.1/jyr9rn4p
Discuss with AI
faecal microbiota transplantationgut microbiotainflammatory bowel diseasemetabolic syndromemulti-omics technologies
Figures from the paper
Abstract (AI)
Over the last 10-15 years, our understanding of the composition and functions of the human gut microbiota has increased exponentially. To a large extent, this has been due to new 'omic' technologies that have facilitated large-scale analysis of the genetic and metabolic profile of this microbial community, revealing it to be comparable in influence to a new organ in the body and offering the possibility of a new route for therapeutic intervention. Moreover, it might be more accurate to think of it like an immune system: a collection of cells that work in unison with the host and that can promote health but sometimes initiate disease. This review gives an update on the current knowledge in the area of gut disorders, in particular metabolic syndrome and obesity-related disease, liver disease, IBD and colorectal cancer. The potential of manipulating the gut microbiota in these disorders is assessed, with an examination of the latest and most relevant evidence relating to antibiotics, probiotics, prebiotics, polyphenols and faecal microbiota transplantation.
Key Findings
1
Advances in omics technologies have revealed the gut microbiota’s extensive genetic and metabolic influence, comparable to that of a body organ.
2
Gut microbiota alterations are relevant to metabolic syndrome, obesity-related disease, liver disease, inflammatory bowel disease, and colorectal cancer.
3
Manipulating the gut microbiota is being evaluated therapeutically using antibiotics, probiotics, prebiotics, polyphenols, and fecal microbiota transplantation.
4
The gut microbiota functions cooperatively with the host like an immune system, promoting health but potentially contributing to disease.
5
The review assesses current evidence and therapeutic potential of microbiota-directed interventions across major gut-associated disorders.
Research Object
Human gut microbiota
Research Subject
Its composition, functions, interactions with host health and disease, and therapeutic manipulability in metabolic syndrome and obesity-related disease, liver disease, inflammatory bowel disease, and colorectal cancer
Publication Details
Publication Date
2015-09-02
Journal
Publisher
ISSN
Cited by
2297
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic2014
The first 1000 cultured species of the human gastrointestinal microbiota2014
Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples2012
Cited by3
Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes2016
High-order interactions distort the functional landscape of microbial consortia2019
Efecto de la adición de dos levaduras a una dieta sin antibióticos sobre algunos aspectos de la función digestiva en lechones recién destetados2026